Improving Glycemic Control in DM2 Patients in the Ambulatory Setting

Completed · Not applicable

Conditions studied: Diabetes Mellitus

In brief

More than 10.5% of the US population has diabetes mellitus. The objective of this pilot study is to evaluate whether smart insulin pens combined with CGM devices can improve glucose control in patients with type 2 diabetes (T2D)

Key facts

Study ID

NCT04800471

Run by

University of Maryland, Baltimore

People needed

30

Starts

2021-08-16

Expected to finish

2024-07-09

Last updated by the study team

2026-02-10

Who can join

Age: 21 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Insulin-treated patients with DM2 (treated with basal-bolus insulin regimens (MDI), ± non-insulin medications) and Uncontrolled glycemic control

You may not qualify if…

• History of type 1 DM (DM1)
• Pregnant Patients
• Extensive skin changes/disease or allergies that preclude wearing the CGM sensor
• Subjects who have end-stage renal disease requiring dialysis
• Significant psychiatric illness or any other condition rendering the subject incapable of understanding the objectives and potential consequences of the study

Where it is running

• Baltimore VA Medical Center — Baltimore, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.